Hidetoshi Igari   Seiichiro Sakao   Takayuki Ishige   Kengo Saito   Shota Murata   Misuzu Yahaba   Toshibumi Taniguchi   Akiko Suganami   Kazuyuki Matsushita   Yutaka Tamura   Takuji Suzuki   Eiji Ido   
Nature Communications 15(1) 2024年4月
Abstract
Numerous SARS-CoV-2 variant strains with altered characteristics have emerged since the onset of the COVID-19 pandemic. Remdesivir (RDV), a ribonucleotide analogue inhibitor of viral RNA polymerase, has become a valuable therapeutic agen...